Nissay Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.9M Buy
185,619
+2,511
+1% +$270K 0.12% 136
2025
Q1
$18.5M Buy
183,108
+2,380
+1% +$240K 0.12% 128
2024
Q4
$16.4M Sell
180,728
-2,385
-1% -$216K 0.1% 139
2024
Q3
$15.3M Buy
183,113
+5,102
+3% +$428K 0.1% 143
2024
Q2
$13.7M Buy
178,011
+5,612
+3% +$432K 0.09% 145
2024
Q1
$11.8M Sell
172,399
-1,712
-1% -$117K 0.08% 163
2023
Q4
$10.1M Buy
174,111
+7,613
+5% +$440K 0.08% 154
2023
Q3
$8.79M Buy
166,498
+5,306
+3% +$280K 0.08% 158
2023
Q2
$8.72M Buy
161,192
+274
+0.2% +$14.8K 0.08% 156
2023
Q1
$8.05M Sell
160,918
-5,643
-3% -$282K 0.07% 162
2022
Q4
$7.71M Sell
166,561
-52
-0% -$2.41K 0.07% 164
2022
Q3
$6.45M Buy
166,613
+6,363
+4% +$246K 0.07% 172
2022
Q2
$5.97M Buy
160,250
+877
+0.6% +$32.7K 0.06% 183
2022
Q1
$7.06M Buy
159,373
+3,678
+2% +$163K 0.06% 191
2021
Q4
$6.61M Buy
155,695
+5,261
+3% +$223K 0.05% 209
2021
Q3
$6.53M Buy
150,434
+6,171
+4% +$268K 0.06% 195
2021
Q2
$6.17M Buy
144,263
+7,678
+6% +$328K 0.05% 203
2021
Q1
$5.28M Sell
136,585
-3,254
-2% -$126K 0.05% 210
2020
Q4
$5.03M Buy
139,839
+743
+0.5% +$26.7K 0.08% 196
2020
Q3
$5.32M Sell
139,096
-21,247
-13% -$812K 0.09% 181
2020
Q2
$5.63M Buy
160,343
+1,436
+0.9% +$50.4K 0.11% 182
2020
Q1
$5.19M Buy
158,907
+4,047
+3% +$132K 0.13% 165
2019
Q4
$7M Sell
154,860
-5,305
-3% -$240K 0.16% 159
2019
Q3
$6.52M Buy
160,165
+6,718
+4% +$273K 0.16% 152
2019
Q2
$6.6M Sell
153,447
-14,490
-9% -$623K 0.17% 143
2019
Q1
$6.45M Sell
167,937
-7,970
-5% -$306K 0.17% 144
2018
Q4
$6.22M Buy
175,907
+5,708
+3% +$202K 0.19% 125
2018
Q3
$6.55M Buy
170,199
+3,679
+2% +$142K 0.18% 142
2018
Q2
$5.45M Sell
166,520
-1,681
-1% -$55K 0.16% 153
2018
Q1
$4.6M Sell
168,201
-8,189
-5% -$224K 0.14% 186
2017
Q4
$4.37M Buy
+176,390
New +$4.37M 0.13% 206